Cargando…

Sann-Joong-Kuey-Jian-Tang induces autophagy in HepG2 cells via regulation of the phosphoinositide-3 kinase/Akt/mammalian target of rapamycin and p38 mitogen-activated protein kinase pathways

Sann-Joong-Kuey-Jian-Tang (SJKJT), a traditional Chinese medicine, was previously reported to induce autophagy and inhibit the proliferation of the human HepG2 hepatocellular carcinoma cell line via an extrinsic pathway. In the present study, the effects of SJKJT-induced autophagy and the cytotoxic...

Descripción completa

Detalles Bibliográficos
Autores principales:	CHUANG, WAN-LING, SU, CHIN-CHENG, LIN, PING-YI, LIN, CHI-CHEN, CHEN, YAO-LI
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	D.A. Spandidos 2015
Materias:	Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4464480/ https://www.ncbi.nlm.nih.gov/pubmed/25847489 http://dx.doi.org/10.3892/mmr.2015.3573

Ejemplares similares

Sanné on Diphtheria
Publicado: (1877)

Tribute to Hans Sann
Publicado: (2003)

Alsterpaullone induces apoptosis of HepG2 cells via a p38 mitogen-activated protein kinase signaling pathway
por: Yin, Peng, et al.
Publicado: (2019)

Antitumor effect of resveratrol on chondrosarcoma cells via phosphoinositide 3-kinase/AKT and p38 mitogen-activated protein kinase pathways
por: Dai, Zixun, et al.
Publicado: (2021)

MicroRNA-21 promotes hepatocellular carcinoma HepG2 cell proliferation through repression of mitogen-activated protein kinase-kinase 3
por: Xu, Guangxian, et al.
Publicado: (2013)

Redox-dependent dimerization of p38α mitogen-activated protein kinase with mitogen-activated protein kinase kinase 3
por: Bassi, Rekha, et al.
Publicado: (2017)

Disease Evolution and Response to Rapamycin in Activated Phosphoinositide 3-Kinase δ Syndrome: The European Society for Immunodeficiencies-Activated Phosphoinositide 3-Kinase δ Syndrome Registry
por: Maccari, Maria Elena, et al.
Publicado: (2018)

Hydroxypyridinone-Coumarin Inhibits the Proliferation of MHCC97 and HepG2 Human Hepatocellular Carcinoma Cells and Down-Regulates the Phosphoinositide-3 Kinase Pathway
por: Cui, Xiaopeng, et al.
Publicado: (2020)

Changes in the Balance of Phosphoinositide 3-Kinase/Protein Kinase B (Akt) and the Mitogen-activated Protein Kinases (ERK/p38MAPK) Determine a Phenotype of Visceral and Vascular Smooth Muscle Cells
por: Hayashi, Ken'ichiro, et al.
Publicado: (1999)

Preface: Invited Issue Editor, Professor Joong-Uhn Choi, and the Era of Neuroendoscopy
por: Kim, Seung-Ki, et al.
Publicado: (2017)

P38 Mitogen-activated Protein Kinase and Parkinson’s Disease
por: He, Jianying, et al.
Publicado: (2018)

Mitogen-activated protein kinase inhibitors reduce the nuclear accumulation of phosphorylated Smads by inhibiting Imp 7 or Imp 8 in HepG2 cells
por: Hu, Xiangpeng, et al.
Publicado: (2018)

Activation of the mitogen‐activated protein kinase ERK1/2 signaling pathway suppresses the expression of ChREBPα and β in HepG2 cells
por: Li, Lan, et al.
Publicado: (2021)

Activation of p38 Mitogen-Activated Protein Kinase in Gaucher’s Disease
por: Kitatani, Kazuyuki, et al.
Publicado: (2015)

Therapeutic Potential of Autophagy in Glioblastoma Treatment With Phosphoinositide 3-Kinase/Protein Kinase B/Mammalian Target of Rapamycin Signaling Pathway Inhibitors
por: Xia, Qin, et al.
Publicado: (2020)

Xihuang pills induce apoptosis in hepatocellular carcinoma by suppressing phosphoinositide 3-kinase/protein kinase-B/mechanistic target of rapamycin pathway
por: Teng, Yong-Jie, et al.
Publicado: (2022)

Inhibitors of phosphoinositide 3-kinase (PI3K) and phosphoinositide 3-kinase-related protein kinase family (PIKK)
por: Huang, Xueqin, et al.
Publicado: (2023)

Effective Inhibition of Xenografts of Hepatocellular Carcinoma (HepG2) by Rapamycin and Bevacizumab in an Intrahepatic Model
por: Ong, Lai-Chun, et al.
Publicado: (2009)

The case for inhibiting p38 mitogen-activated protein kinase in heart failure
por: Arabacilar, Pelin, et al.
Publicado: (2015)

Sagunja-Tang Improves Lipid Related Disease in a Postmenopausal Rat Model and HepG2 Cells
por: Go, Hiroe, et al.
Publicado: (2015)

Rapamycin reduces orofacial nociceptive responses and microglial p38 mitogen-activated protein kinase phosphorylation in trigeminal nucleus caudalis in mouse orofacial formalin model
por: Yeo, Ji-Hee, et al.
Publicado: (2021)

p38 mitogen-activated protein kinase and mitogen-activated protein kinase-activated protein kinase 2 (MK2) signaling in atrophic and hypertrophic denervated mouse skeletal muscle
por: Evertsson, Kim, et al.
Publicado: (2014)

Src Family Kinases and p38 Mitogen-Activated Protein Kinases Regulate Pluripotent Cell Differentiation in Culture
por: Tan, Boon Siang Nicholas, et al.
Publicado: (2016)

Phosphoinositide 3-Kinase–Dependent Membrane Recruitment of P62(dok) Is Essential for Its Negative Effect on Mitogen-Activated Protein (Map) Kinase Activation
por: Zhao, Mingming, et al.
Publicado: (2001)

Correlations between Insulin Receptor Substrate-1 with Phosphoinositide 3-Kinase and P38 Mitogen-Activated Protein Kinase Levels after Treatment of Diabetic Rats with Puguntano (Curanga Fel-Terrae [Merr.]) Leaf Extract
por: Syafril, Santi, et al.
Publicado: (2019)

Mechanism of TangGanJian on nonalcoholic fatty liver disease with type 2 diabetes mellitus
por: Fan, Yanbo, et al.
Publicado: (2018)

Retracted: Sagunja-Tang Improves Lipid Related Disease in a Postmenopausal Rat Model and HepG2 Cells
por: Evidence-Based Complementary and Alternative Medicine,
Publicado: (2016)

Full Activation of Kinase Protein Kinase B by Phosphoinositide-Dependent Protein Kinase-1 and Mammalian Target of Rapamycin Complex 2 Is Required for Early Natural Killer Cell Development and Survival
por: He, Junming, et al.
Publicado: (2021)

The activation of p38alpha, and not p38beta, mitogen-activated protein kinase is required for ischemic preconditioning
por: Sicard, Pierre, et al.
Publicado: (2010)

The p38 mitogen-activated protein kinase signaling cascade in CD4 T cells
por: Dodeller, Francis, et al.
Publicado: (2006)

An Inhibition of p38 Mitogen Activated Protein Kinase Delays the Platelet Storage Lesion
por: Skripchenko, Andrey, et al.
Publicado: (2013)

Safety and efficacy of p38 mitogen-activated protein kinase inhibitors (MAPKIs) in COPD
por: Yu, Haichuan, et al.
Publicado: (2022)

Stress signaler p38 mitogen-activated kinase activation: a cause for concern?
por: Radnaa, Enkhtuya, et al.
Publicado: (2022)

Metformin inhibits the proliferation of A549/CDDP cells by activating p38 mitogen-activated protein kinase
por: WANG, YAJUN, et al.
Publicado: (2014)

Reveal the Mechanisms of Yi-Fei-Jian-Pi-Tang on Covid-19 through Network Pharmacology Approach
por: Lang, Wanying, et al.
Publicado: (2022)

p38γ and p38δ Mitogen Activated Protein Kinases (MAPKs), New Stars in the MAPK Galaxy
por: Escós, Alejandra, et al.
Publicado: (2016)

Receptor tyrosine kinase inhibitors block proliferation of TGEV mainly through p38 mitogen-activated protein kinase pathways
por: Dong, Wanyu, et al.
Publicado: (2020)

Genome-wide identification and transcriptional expression analysis of mitogen-activated protein kinase and mitogen-activated protein kinase kinase genes in Capsicum annuum
por: Liu, Zhiqin, et al.
Publicado: (2015)

Activin A induces skeletal muscle catabolism via p38β mitogen‐activated protein kinase
por: Ding, Hui, et al.
Publicado: (2016)

Chondrocyte response to growth factors is modulated by p38 mitogen-activated protein kinase inhibition
por: Studer, Rebecca K, et al.
Publicado: (2004)

Cannot write session to /tmp/vufind_sessions/sess_i8qh9furp18u33ch0v5jt794qc